Meeting NewsPerspective

Prototype assays may facilitate development of blood tests for early cancer detection

April 17, 2018
CHICAGO — Prototype sequencing assays evaluated in the Circulating Cell-free Genome Atlas study may contribute to the development of a highly…

CMEABIM MOC

Ace the Case: A 33-Year-Old Woman with a Mass in Her Right Breast

April 16, 2018 Expires: 4/15/2019
This educational activity will utilize a case study to discuss the diagnosis and management of a breast mass in a 33-year-old woman.

There is no commercial support for this activity.

American Association for Cancer Research presents special recognition awards

April 16, 2018
The American Association for Cancer Research will present special recognition awards to four individuals whose work has made extraordinary…

Meeting News

Abemaciclib effective as initial therapy for certain women with advanced breast cancer

April 15, 2018
CHICAGO — The addition of abemaciclib to initial treatment with a nonsteroidal aromatase inhibitor appeared effective for women with hormone…

Meeting News

Taselisib monotherapy appears active in PIK3CA-mutated solid tumors

April 15, 2018
CHICAGO — Taselisib demonstrated preliminary clinical activity and exhibited an acceptable safety profile as monotherapy for patients with…

In the Journals Plus

Male BRCA carriers at risk for melanoma, pancreatic cancer

April 13, 2018
It may be appropriate to screen for melanoma and pancreatic cancer in addition to prostate and breast cancer among men carrying BRCA mutations…

Point/Counter

Should neoadjuvant carboplatin be used for triple-negative breast cancer?

HemOnc Today, April 10, 2018
POINT Carboplatin is a potentially life-saving treatment option for advanced clinical stage triple-negative breast cancers.

Cover Story

Deeper understanding of disease biology may improve outcomes in triple-negative breast cancer

HemOnc Today, April 10, 2018
The discovery of predictive biomarkers and the subsequent development of effective targeted therapies have dramatically improved breast cancer…

Northwestern University Feinberg School of Medicine appoints hematology/oncology division chief

April 7, 2018
William J. Gradishar, MD, has been appointed chief of the division of hematology and oncology in the department of medicine at Northwestern…

FDA News

FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion

April 6, 2018
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a…

In the Journals Plus

Exercise a ‘form of medicine’ for breast cancer survivors

April 5, 2018
A combination of aerobic and resistance exercise improved sarcopenic obesity, metabolic syndrome and serum biomarkers among breast cancer survivors…

In the Journals Plus

Breast density improves prediction of long-term breast cancer risk

April 5, 2018
A risk model that combined classical risk factors with breast density information stratified women at high risk for breast cancer up to 19 years…

Meeting News

Polygenic risk scores may predict risk for second breast cancer

April 3, 2018
Polygenic risk scores appeared to predict contralateral breast cancer among survivors who harbored BRCA1 and BRCA2 mutations, according to findings…

Meeting News

Double mastectomy may reduce risk for cancer, death among BRCA1 carriers

April 2, 2018
Healthy women who carried the BRCA1 mutation had reduced risk for developing breast cancer and mortality if they underwent bilateral risk-reducing…

Meeting News

Researchers identify factors associated with lower breast cancer recurrence risk

March 27, 2018
Postmenopausal women and those with ER-positive tumors appeared less likely to experience ductal carcinoma in situ recurrence, according to results…

In the Journals

ACO enrollment associated with more appropriate breast, colorectal cancer screening

March 19, 2018
Enrolling in Medicare Shared Savings Program Accountable Care Organizations led to improvements in appropriateness of breast and colorectal cancer…

Meeting News

Breast cancer scientist receives award for translational research

March 18, 2018
V. Craig Jordan, OBE, DSc, PhD, the Dallas/Ft. Worth Living Legend Chair of Cancer Research and professor of breast oncology and molecular and…

Meeting News

HER-2 mutations linked to hormone therapy resistance in breast cancer subtype

March 16, 2018
HER-2 mutations appeared associated with resistance to hormone therapy among women with ER-positive metastatic breast cancer, according to a study…

Guidelines

ASTRO issues guidelines for whole breast radiation therapy

March 12, 2018
A new guideline issued by the American Society for Radiation Oncology recommends the use of hypofractionated whole breast irradiation for patients…

In the Journals Plus

Genetic counseling underused for breast cancer

March 12, 2018
Only half of women with newly diagnosed breast cancer who could benefit from genetic counseling received it, according to study results published in…